ABHAY KUMAR SRIVASTAVA

      DIN: 08040683

      For latest information about the director, visit MCA.

      ABHAY KUMAR SRIVASTAVA is a director registered with Ministry of Corporate Affairs. Their Director Identification Number (DIN) is 08040683. ABHAY KUMAR SRIVASTAVA is/has been associated with 20 companies.

      This is just one Director. Want to discover lot more?

      Unlock deeper insights with Prime Research AI

      Companies Associated With

      Company Designation Date of Appointment
      SIRMOUR REMEDIES PRIVATE LIMITED Director 29-Sep-2021
      MANKIND MEDICARE PRIVATE LIMITED Director 12-Sep-2023
      MANKIND LIFE SCIENCES PRIVATE LIMITED Director 24-Dec-2021
      MANKIND PETCARE PRIVATE LIMITED Director 20-Oct-2021
      RELAX PHARMACEUTICALS PRIVATE LIMITED Director 27-Nov-2021
      JPR LABS PRIVATE LIMITED Director 29-Sep-2018
      SHREE JEE LABORATORY PRIVATE LIMITED Whole-time director 29-Jan-2019
      MANKIND AGRITECH PRIVATE LIMITED Director 06-Apr-2022
      MEDIFORCE HEALTHCARE PRIVATE LIMITED Director 30-Nov-2021
      MANKIND PRIME LABS PRIVATE LIMITED Director 24-Dec-2021
      COPMED PHARMACEUTICALS PRIVATE LIMITED Director 30-Nov-2021

      Past Companies Associated With

      Company Designation Date of Appointment Date of Cessation
      SIRMOUR REMEDIES PRIVATE LIMITED Additional Director 01-Mar-2021 29-Sep-2021
      MANKIND LIFE SCIENCES PRIVATE LIMITED Additional Director 17-Sep-2021 24-Dec-2021
      RELAX PHARMACEUTICALS PRIVATE LIMITED Additional Director 01-Mar-2021 27-Nov-2021
      JPR LABS PRIVATE LIMITED Additional Director 01-Mar-2018 29-Sep-2018
      SHREE JEE LABORATORY PRIVATE LIMITED Additional Director 02-May-2018 29-Sep-2018
      SHREE JEE LABORATORY PRIVATE LIMITED Director 29-Sep-2018 29-Jan-2019
      MEDIFORCE HEALTHCARE PRIVATE LIMITED Additional Director 01-Mar-2021 30-Nov-2021
      MANKIND PRIME LABS PRIVATE LIMITED Additional Director 30-Jun-2021 24-Dec-2021
      COPMED PHARMACEUTICALS PRIVATE LIMITED Additional Director 01-Mar-2021 30-Nov-2021

      “Assess financial performance of all companies under a director.”

      Explore Prime Research Explore for Sales